Oncology CRO Services

A full-service oncology CRO for complex oncology clinical trials

Medelis’ world-class medical and project teams have extensive experience in the design, performance and analysis of complex clinical trials.¬† With this focus, we offer the seasoning and insight only long practice in complex studies can produce.

With our full-service offering, we can create and implement a detailed drug development plan carefully structured to address all regulatory needs and requirements. We’ll optimize the likely outcomes for your agent with respect to follow-on studies and additional indications, delivering maximum value for your clinical investment.

Our specialization in oncology CRO services provides clients with:

  • Access to a world-class medical team with extensive experience in the design, performance and analysis of complex clinical trials
  • A single partner from pre-clinical through phase III trials
  • Team members with first-hand clinical knowledge of tumor types and drugs and true understanding of the diseases and investigational agents being studies
  • Experience in managing dose escalation and determining maximum tolerated dose
  • Experience in safety assessment
  • Close working relationships with expert investigators
  • Unique investigator and patient recruitment programs to help get the right patients in your trial

Oncology CRO services in North America and Europe

For sponsors looking for a true partner to trust throughout the oncology drug development process, Medelis provides:

  • Preclinical development
  • Study design
  • Study launch
  • Study management
  • Medical writing
  • Data management & biostatistics
  • Regulatory affairs and QA

Our team is accustomed to handling most targets in oncology.  This portfolio of expertise means faster, more accurate results and more strategic long-term development planning.

Contact us to learn more about our services, or to discuss your upcoming trial.